Monetisation? That's a fair question and one I think we all have. Never easy from a revenue perspective when your product is disruptive. The partnerships they're forming plus the industry taliwinds from legislation are why I'm in but not expecting it to happen in the first 12 months. Maybe CF+ in H2-2017 or H1-2018. As long as the market can see they're progressing and revenue is at least pushing along, should do ok.
Monetisation? That's a fair question and one I think we all...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
